101. Use of collagen sponge incorporating transforming growth factor-beta1 to promote bone repair in skull defects in rabbits
- Author
-
Hiroki Ueda, Masatoshi Inoue, Tatsuo Nakamura, Liu Hong, Toshinari Toba, Keiji Shigeno, Masaya Yamamoto, Yasuhiko Shimizu, Yasuhiko Tabata, and Makoto Yoshitani
- Subjects
Surgical Sponges ,Materials science ,medicine.medical_treatment ,Biophysics ,Bioengineering ,Biocompatible Materials ,Bone healing ,Biomaterials ,Transforming Growth Factor beta1 ,Mice ,In vivo ,Transforming Growth Factor beta ,Materials Testing ,medicine ,Animals ,Saline ,Fracture Healing ,Drug Carriers ,biology ,Skull Fractures ,biology.organism_classification ,Controlled release ,In vitro ,Recombinant Proteins ,Sponge ,Mechanics of Materials ,Delayed-Action Preparations ,Ceramics and Composites ,Microscopy, Electron, Scanning ,Female ,Collagen ,Rabbits ,Drug carrier ,Biomedical engineering - Abstract
The objective of this study was to evaluate the potential of collagen sponge incorporating transforming growth factor-beta1 (TGF-beta1) to enhance bone repair. The collagen sponge was prepared by freeze-drying aqueous foamed collagen solution. Thermal cross-linking was performed in a vacuum at 140 degrees C for periods ranging from 1 to 48 h to prepare a number of fine collagen sponges. When collagen sponges incorporating 125I-labeled TGF-beta1 were placed in phosphate-buffered saline (PBS) solution at 37 degrees C, a small amount of TGF-beta1 was released for the first hour, but no further release was observed thereafter, irrespective of the amount of cross-linking time the sponges had received. Collagen sponges incorporating 125I-labeled TGF-beta1 or simply labeled with 125I were implanted into the skin on the backs of mice. The radioactivity of the 125I-labeled TGF-beta1 in the collagen sponges decreased with time; the amount of TGF-beta1 remaining dependent on the cross-linking time. The in vivo retention of TGF-beta1 was longer in those sponges that had been subjected to longer cross-linking times. The in vivo release profile of the TGF-beta1 was matched with the degradation profile of the sponges. Scanning electron microscopic observation revealed no difference in structure among sponges subjected to different cross-linking times. The TGF-beta1 immobilized in the sponges was probably released in vivo as a result of sponge biodegradation because TGF-beta1 release did not occur in in vitro conditions in which sponges did not degrade. We applied collagen sponges incorporating 0.1 microg of TGF-beta1 to skull defects in rabbits in stress-unloaded bone situations. Six weeks later, the skull defects were covered by newly formed bone, in marked contrast to the results obtained with a TGF-beta1 free empty collagen sponge and 0.1 microg of free TGF-beta1. We concluded that the collagen sponges were able to release biologically active TGF-beta1 and were a promising material for bone repair.
- Published
- 2002